
LifeMD (LFMD) Stock Forecast & Price Target
LifeMD (LFMD) Analyst Ratings
Bulls say
LifeMD is likely to experience significant growth in the near future due to their innovative telehealth platform, which includes key capabilities like a nationwide pharmacy network and AI-enabled technologies. This, along with their recent collaboration with AT&T and launch of a new FDA-approved product, is expected to drive revenue and profits. Risks to their expected growth include competition and potential dilution, but overall, LifeMD is well-positioned to capitalize on the growing demand for telehealth services and direct-to-consumer healthcare options.
Bears say
LifeMD is a high-growth, direct-to-consumer healthcare company that has seen recent success with telehealth and partnerships with insurance companies. However, their transition away from compounded GLP-1 medications has negatively affected short-term profitability. While long-term prospects are positive with the potential for Medicare growth and new partnerships, it may take time for the company to fully reap the benefits of its investments.
This aggregate rating is based on analysts' research of LifeMD and is not a guaranteed prediction by Public.com or investment advice.
LifeMD (LFMD) Analyst Forecast & Price Prediction
Start investing in LifeMD (LFMD)
Order type
Buy in
Order amount
Est. shares
0 shares